Aandelen in “Medische Specialiteiten”

Aandeel Datum Koers Evolutie
vlag Koninklijke Philips NV 11/11 30,200 USD
-0,69% 		-0,69%

Nieuws over “Medische Specialiteiten”

11/11 · Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments · Persbericht

11/11 · Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments · Persbericht

11/11 · Form-8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC - 10 11 2026 - (CGWL) · Persbericht

10/11 · EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2026 · Persbericht

10/11 · Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update · Persbericht

10/11 · Waters Achieves FDA 510(k) Clearance for Ready-to-Use Flow Cytometry Clinical Tests for Leukemia and Lymphoma · Persbericht

10/11 · Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments · Persbericht

10/11 · Form-8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC - 09 11 2026 - (CGWL) · Persbericht

9/11 · QuidelOrtho Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into QuidelOrtho (QDEL) · Persbericht

9/11 · PharmaLogic to Acquire Lantheus' CDMO Business and Springfield, New Jersey Manufacturing Facility · Persbericht

9/11 · Raised Outlooks and a Cancer Approval Arrive in the Middle of Medicare Open Enrollment · Persbericht

9/11 · Philips Avent Launches New Natural Response Glass Baby Bottle with a Lighter, Stronger Design · Persbericht

9/11 · Philips Avent Launches New Natural Response Glass Baby Bottle with a Lighter, Stronger Design · Persbericht

9/11 · INVESTOR DEADLINE: Tenax Therapeutics, Inc. (TENX) Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 28, 2026 Deadline · Persbericht

9/11 · Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments · Persbericht

9/11 · NAMSA and Advanced Medical Solutions Announce Preferred Partnership · Persbericht

9/11 · Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London · Persbericht

9/11 · CytoSorbents to Participate at the 2026 Jefferies Global Healthcare Conference in London · Persbericht

9/11 · TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS Law · Persbericht

7/11 · TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS Law · Persbericht

6/11 · IRTC Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into iRhythm Technologies, Inc. (IRTC) · Persbericht

Mijn selecties